The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome by Pengju Liu et al.
Liu et al. BMC Public Health 2013, 13:629
http://www.biomedcentral.com/1471-2458/13/629RESEARCH ARTICLE Open AccessThe utility of fat mass index vs. body mass index
and percentage of body fat in the screening of
metabolic syndrome
Pengju Liu1, Fang Ma1,3*, Huiping Lou2 and Yanping Liu1Abstract
Background: It has been well documented that obesity is closely associated with metabolic syndrome (MetS).
Although body mass index (BMI) is the most frequently used method to assess overweightness and obesity, this
method has been criticized because BMI does not always reflect true body fatness, which may be better evaluated
by assessment of body fat and fat-free mass. The objective of this study was to investigate the best indicator to
predict the presence of MetS among fat mass index, BMI and percentage of body fat (BF %) and determine its
optimal cut-off value in the screening of MetS in practice.
Methods: A cross-sectional study of 1698 subjects (aged 20–79 years) who participated in the annual health check-ups
was employed. Body composition was measured by bioelectrical impedance analysis (BIA). Fat mass index (FMI) was
calculated. Sex-specific FMI quartiles were defined as follows: Q1: <4.39, Q2:4.39- < 5.65, Q3:5.65- < 7.03, Q4:≥7.03,in
men; and Q1:<5.25, Q2:5.25- < 6.33, Q3:6.33- < 7.93,Q4:≥7.93, in women. MetS was defined by National Cholesterol
Education Program/Adult Treatment Panel III criteria. The association between FMI quartiles and MetS was assessed
using Binary logistic regression. Receiver operating curve(ROC) analysis was used to determine optimal cutoff points for
BMI,BF% and FMI in relation to the area under the curve(AUC),sensitivity and specificity in men and women.
Results: The adjusted odds ratios (95% CI) for the presence of MetS in the highest FMI quartile versus lowest quartile
were 79.143(21.243-294.852) for men( P < 0.01) and 52.039(4.144-653.436) for women( P < 0.01) after adjusting age, BMI,
BF%, TC, LDL, CRP, smoking status and exercise status, and the odds ratios were 9.166(2.157-38.952) for men( P < 0.01)
and 25.574(1.945-336.228) for women( P < 0.05) when WC was also added into the adjustment. It was determined that
BMI values of 27.45 and 23.85 kg/m2, BF% of 23.95% and 31.35% and FMI of 7.00 and 7.90 kg/m2 were the optimal
cutoff values to predict the presence of MetS among men and women according to the ROC curve analysis. Among
the indicators used to predict MetS, FMI was the index that showed the greatest area under the ROC curve in
both sexes.
Conclusions: Higher FMI levels appear to be independently and positively associated with the presence of MetS
regardless of BMI and BF%. FMI seems to be a better screening tool in prediction of the presence of metabolic
syndrome than BMI and percentage of body fat in men and women.
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Obesity is one of basic clinical conditions of metabolic
syndrome (MetS), which is a cluster of risk factors for
cardiovascular disease (CVD). The clustering of factors
includes overweight/obesity, hyperinsulinemia, hyperten-
sion, hyperlipidemia, fasting hyperglucose or type 2 dia-
betes mellitus, and obesity (particularly central obesity)
plays a central role in the MetS [1]. The growing preva-
lence of overweight and obesity are established risk fac-
tors for the metabolic syndrome [2].
Although body mass index (BMI) is the most fre-
quently used method to assess overweightness and obes-
ity, this method has been criticized because BMI does
not always reflect true body fatness [3-6] and has some
limitations in assessing the risk of obesity-related dis-
eases in persons with low muscle and high body fat [7],
and in individuals with increased body fat and normal
BMI. A recent study [8] reported that normal weight
obesity was associated with MetS and insulin resistance,
and suggested that clinical assessment of excess body fat
in normal-BMI individuals should begin early in life. It
seems that true body fatness may be better evaluated by
assessment of body fat and fat-free mass [9]. Therefore,
much research has recently examined the potential role
of body composition measurements [7,10-14].
Until now, bioelectrical impedance analysis (BIA) has
been considered as the simplest, most reproducible and
least expensive method for body composition evaluation in
clinical practice, and it showed high accuracy and excellent
correlation with dual-energy X-ray absorptiometry(DXA)
in assessing BF% [15-17]. Therefore, BIA is considered the
most cost-effective and feasible replacement for DXA in
assessing body composition. BF% has been most commonly
used in practice. However, the accuracy of BF% measure-
ments is dependent on height and cannot be evaluated
independently from fat free mass (FFM) [18]. Moreover,
percentage of body fat does not adjust appropriately for
body size, although height has recently been reported as an
independent risk factor for CVD [19]. Therefore, both fat
mass and fat-free mass should be normalized for body size
[20]. Acknowledging such a problem, VanItallie et al. pro-
posed a fat-free mass index (FFMI; FFM⁄ height2) and a fat
mass index (FMI; FMI ⁄ height2) that considers an individ-
ual’s height [21]. FMI and FFMI are calculated by dividing
fat mass (FM) and fat-free mass (FFM) by the square of
height. These calculated body fat indices eliminate the dif-
ferences of the BF% associated with one’s height, can inde-
pendently evaluate body fatness from changes in FFM, and
therefore, could be a useful measure of obesity [22-24].
The objective of this study was to investigate the best
indicator to predict the presence of MetS among fat
mass index, BMI and percentage of body fat (BF%) and
determine its optimal cut-off value in the screening of
MetS in practice.Methods
Subjects in the study were enrolled from 2179 people
who participated in the annual health check-up in the
Department of Medical examination center, Peking Union
Medical College Hospital, China Academic Medical Science
and Peking Union Medical College, China, in 2011(from
January to July). A standard questionnaire was used by
trained physicians to collect related information including
age, sex, physical activity, smoking, and medication use,
and then routine physical examinations were performed
to all subjects, and two blood pressure recordings were
obtained from the right arm of subjects in a sitting position
after 30 min of rest; Diabetes or hypertension were re-
corded if a participant gave a positive answer to the ques-
tion: Have you ever been diagnosed by a physician as
diabetes or hypertension? Smoking status was categorized
as current smokers and non-smokers (nonsmokers or stop
smoking for at least 6 months). People who exercised three
or more times a week for >30 minutes were categorized as
the regular exercise group, and those who exercised less
than three times a week were considered the non-regular
group. The exclusion criteria were as the follows: 1) with
the evidence of cancer, renal, or hematological disease; 2)
a medication history of corticosteroids in the previous
6 months; 3) those who were going on a weight-loss pro-
gram or weight loss ≥5% of body weight within 12 months;
4) people who refused to participate in this study.
Finally, 1698 subjects aged 20 ~ 79 years were enrolled
in the study (1105 men and 593 women). All of the study
procedures were approved by the Ethics Committee of
Peking Union Medical College Hospital, China Academic
Medical Science. All subjects provided informed consent to
participate in the study.
Anthropometric measurements
Anthropometric measurements of individuals wearing
light clothing and without shoes were conducted by
well-trained examiners. Height was measured to the
nearest 0.1 cm with a portable stadiometer. Weight was
measured in an upright position to the nearest 0.1 kg
with a calibrated scale. Body mass index was calculated
by dividing weight (kg) by height squared (m2). Waist
circumference measurements were taken at the end of
normal expiration to the nearest 0.1 cm, measuring from
the midway between the lower borders of the rib cage
and the iliac crest.
Body composition measurements
Fat mass, percent body fat were measured by multi-
frequency bioelectric impedance analysis (multi-frequency
bioelectric impedance analyzer Inbody 720, 8 contact point,
5, 50, 250, and 500 kHz,Biospace Co. Ltd., Seoul, Korea).
Four electrodes were placed on the palm and thumb of
both hands, and four on the anterior and posterior aspects
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culated by dividing the each subject’s fat mass (kg) by
square of his/her height (m). FMI levels were divided into
separate quartiles for men and women. Sex-specific FMI
quartiles were used as follows: Q1: <4.39, Q2: 4.39- < 5.65,
Q3: 5.65- < 7.03, Q4: ≥7.03, in men; and Q1: <5.25, Q2:
5.25- < 6.33, Q3: 6.33- < 7.93, Q4: ≥7.93, in women.
Biochemical measurements
Blood sample were collected from the subjects’ peripheral
vein in the morning after a fasting period of 10–12 h. the
samples were immediately centrifuged at 4°C, and plasma
for assays of lipid profile (including total cholesterol (TC),
triglyceride (TG), low-density-lipoprotein cholesterol (LDL-
C), and high-density-lipoprotein cholesterol (HDL-C)), fast-
ing blood glucose (FBG), C-reactive protein (CRP), using
an automated analyzer (Olympus AU5400, Japan).
Definition of metabolic syndrome and overweight/obesity
The MetS was defined using the updated National
Cholesterol Education Program/Adult Treatment Panel
III criteria (NCEP-ATP III) [25] for Asian Americans as
having ≥3 of the following components: waist circumfer-
ence ≥ 90 cm for men or ≥80 cm for women; triglycer-
ides ≥1.7 mmol/L; HDL cholesterol <1.03 mmol/L for
men or <1.30 mmol/L for women; blood pressure ≥130/
85 mm Hg or current use of antihypertensive medications;
or fasting glucose ≥5.6 mmol/L, type 2 diabetes mellitus
previously diagnosed by a physician, or current use of
antidiabetic medications. Overweight and obesity were de-
fined as a participant with body mass index (BMI) ≥24Table 1 The general characteristics according to sex
Variables Men(n = 1
Age(yr) 46.96 ± 8
Body mass index(kg/m2) 26.01 ± 3
Fat mass index(kg/m2) 5.78 ± 2
Percentage of body fat(%) 21.59 ± 6
Waist circumference(cm) 84.67 ± 7
Systolic blood pressure(mmHg) 124.24 ± 1
Diastolic blood pressure(mmHg) 77.34 ± 1
Total cholesterol(mmol/L) 4.95 ± 0
Triglyceride(mmol/L) 2.03 ± 1
High-density-lipoprotein cholesterol(mmol/L) 1.12 ± 0
Low-density-lipoprotein cholesterol(mmol/L) 3.12 ± 0
Fasting blood glucose(mmol/L) 5.51 ± 1
C-reactive protein(mg/L) 1.84 ± 2
Prevalence of MetS (%/n) 21.00/2
Percentage of Smokers (%/n) 38.40/4
Percentage of regular exerciser (%/n) 32.3/35and <28 kg/m2, and BMI ≥28 kg/m2 respectively, according
to the cut-off point [26] for Chinese adults, or BF% ≥ 25%
(men) and BF% ≥ 30% (women).
Statistical analysis
Statistical analysis were performed separately according
to sex by using the Statistical Package for Social Science
(SPSS version 11.5, Chicago, IL, USA) continuous vari-
ables were expressed as means ± SD, whereas categorical
variables were represented by frequency and percentage.
The differences between two sexes and two groups
(Mets group and non- Mets group) were examined by t-
test for continuous variables and by X2 test for categor-
ical variables, respectively. The association between the
sex-specific fat mass index quartile and metabolic syn-
drome were tested using Binary Logistic regression ana-
lysis, and we calculated the unadjusted and adjusted
odds ratio (ORs) using the lowest quartile as the refer-
ence. Receiver operating curve (ROC) analysis were used
to determine optimal cutoff points for BMI, FMI and BF%
in relation to the area under the curve (AUC), sensitivity
and specificity in men and women. The values of FMI,
BMI and BF% that resulted in maximizing the Youden
index (sensitivity + specificity-1) were defined as optimal.
P < 0.05 was considered significant for all the statistical
analysis.
Results
The characteristics of the 1698 participants are summa-
rized in Table 1. In this study population, 232 men
(21.00%) and 109 women (18.40%) were diagnosed with105) Women(n = 593) P value
.46 46.45 ± 10.79 0.319
.02 23.31 ± 3.36 0.000
.12 6.74 ± 2.25 0.000
.11 28.11 ± 5.91 0.000
.35 77.81 ± 6.60 0.000
7.84 124.83 ± 21.63 0.565
1.95 73.17 ± 11.1 0.000
.91 4.79 ± 0.90 0.001
.43 1.29 ± 0.90 0.000
.25 1.38 ± 0.31 0.000
.79 2.94 ± 0.78 0.000
.25 5.09 ± 0.89 0.000




Table 2 The descriptive characteristics of participantsts with and without MetS in both sexes
Men Women
Variables MetS non-MetS P value MetS non-MetS P value
Age(yr) 46.98 ± 7.38 46.96 ± 8.73 0.971 52.25 ± 9.56 45.15 ± 10.63 0.000
BMI(kg/m2) 29.49 ± 2.59 25.09 ± 2.39 0.000 27.33 ± 3.38 22.41 ± 2.61 0.000
WC(cm) 93.84 ± 6.28 82.23 ± 5.43 0.000 85.94 ± 6.68 75.98 ± 5.02 0.000
BF(%) 27.88 ± 4.67 19.92 ± 5.31 0.000 34.11 ± 4.58 26.76 ± 5.30 0.000
FMI(kg/m2) 8.33 ± 1.87 5.10 ± 1.60 0.000 9.46 ± 2.22 6.12 ± 1.75 0.000
SBP(mmHg) 129.15 ± 17.76 122.93 ± 17.64 0.000 138.82 ± 20.65 121.69 ± 20.60 0.000
DBP(mmHg) 84.00 ± 11.48 75.57 ± 11.45 0.000 79.72 ± 12.39 71.69 ± 10.36 0.000
TC(mmol/L) 4.94 ± 0.91 4.95 ± 0.91 0.921 4.92 ± 1.01 4.76 ± 0.87 0.118
TG(mmol/L) 3.19 ± 2.21 1.73 ± 0.98 0.000 2.24 ± 1.36 1.08 ± 0.58 0.000
HDL(mmol/L) 0.99 ± 0.21 1.16 ± 0.25 0.000 1.12 ± 0.22 1.44 ± 0.30 0.000
LDL(mmol/L) 2.99 ± 0.89 3.16 ± 0.76 0.008 3.03 ± 0.83 2.93 ± 0.76 0.238
FBG((mmol/L)) 6.42 ± 1.77 5.27 ± 0.93 0.000 5.84 ± 1.67 4.92 ± 0.43 0.000
CRP(mg/L) 2.60 ± 2.37 1.64 ± 1.98 0.000 2.02 ± 1.88 1.23 ± 1.79 0.000
Current smokers(%) 40.10 37.90 0.545 21.1 18.8 0.582
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rameters (including BMI, WC, DBP, TC, TG, LDL, FBG,
CRP) and the percentage of smokers were significantly
higher in men than in women (P < 0.001), but the mean
HDL, BF%, FMI, and the percentage of regular exerciser
were significantly lower in men than in women (P <
0.001). No significant differences in the mean of age or
SBP and in the prevalence of MetS were found between
men and women.
In MetS group for both sexes (Table 2), variables in-
cluding BMI, WC, WHtR, WHR, BF%, FMI, SBP, DBP,
TG, FBG, and CRP were significantly higher than those
in non- MetS group (P < 0.001), but HDL was signifi-
cantly lower than that in non- MetS group (P < 0.001).
No significant differences in the mean of TC or the per-
centage of current smokers were found between MetS
group and non- MetS group for both sexes. In addition,
percentage of regular exercise (P = 0.008) and mean LDL
(P = 0.007) in MetS group of men were significantly
lower than in non- MetS group, and mean age in MetS
group of women was higher than in non- MetS group









Q1 Q2 Q3 Q4
Men
Women
Figure 1 Prevalence of metabolic syndrome (MetS) according
to the FMI quartiles.The prevalence of MetS according to FMI quartiles
The prevalence of MetS in each FMI quartile level were
1.44%, 3.24%, 13.10% and 66.55% for men, and 0.70%,
2.70%, 14.86 and 55.41 for women, respectively. The
prevalence of MetS significantly increased in 3rd and 4th
FMI quartiles for both men and women (P < 0.001 for
both sexes) (Figure 1).Odds ratio and 95% confidence intervals for the presence
of MetS using the lowest FMI quartile as the reference
Table 3 shows the risk of MetS according to the FMI
quartiles. After adjustment for age, BMI, BF%, TC, LDL,
CRP, smoking status and exercise status, the 3rd and 4th
FMI quartiles had significantly higher Odds ratio for
metabolic syndrome than the lowest quartile in both
sexes. The adjusted OR (95% CI) for the presence of
metabolic syndrome in subjects with the highest FMI
quartile was 52.039 (4.144-653.436) for women and
79.143 (21.243-294.852) for men, as compared to the
subjects with the lowest FMI quartile. When WC was
added as a additional adjusted factor into regression ana-
lysis, the 3rd and 4th quartiles of FMI for men and the
4th quartile of FMI for women also had significantly
Table 3 Odds ratio and 95% confidence intervals for the presence of MetS according to the FMI quartiles in men and women
Odds ratio(95% confidence interval)
Gender FMI(kg/m2) Unadjusted Adjusted* Adjusted $
Women Quartile 1(<5.25) 1 1 1
Quartile 2(5.25-6.33) 4.083(0.451-36.975) 2.722(0.288-25.749) 3.127(0.340-30.464)
Quartile 3(6.33-7.93) 25.465(3.385-191.583)^ 10.584(1.190-94.111)# 8.397(0.917-76.883)
Quartile 4(>7.93) 182.636(24.887-1340.296)^ 52.039(4.144-653.436)& 25.574(1.945-336.228)#
Men Quartile 1(<4.39) 1 1 1
Quartile 2(4.39-5.65) 2.283(0.695-7.504) 1.329(0.380-4.650) 1.305(0.372-4.584)
Quartile 3(5.65-7.03) 10.280(3.607-29.304)^ 4.698(1.480-14.909)# 3.860(1.203-12.392)#
Quartile 4(>7.03) 135.758(49.031-375.890)^ 79.143(21.243-294.852)& 9.166(2.157-38.952)&
*Adjusted for age, smoking status, exercise status, total cholesterol, low-density-lipoprotein cholesterol, percentage of body fat and C-reactive protein. $ added
WC into * model; # P < 0.05; & P < 0.01; ^ P < 0.001.
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lowest quartile.
Other parameters’ odds ratio and 95% confidence
intervals for the presence of MetS using the lowest FMI
quartile as the reference
According to Binary logistic regression analysis, besides
high FMI level, overall overweight or obesity, and elevated
CRP level, were independently associated with MetS in
men (X2 = 51.032, P < 0.001), whereas in women subjects,
age, overall overweight or obesity, and elevated CRP level
were independently associated with MetS (X2 = 36.327,
P < 0.001). Odds ratio of MetS in both sexes were shown
in Table 4.
ROC curve analysis of MetS-associated indicators to
predict MetS
The areas under ROC curve, the cutoff values, and the
most appropriate sensitivities and specificities of the in-
dicators are presented in Table 5.
As shown in Figure 2 and 3, which include the ROC
curves of BMI, BF%, and FMI, It can be observed that
the line referring to the FMI possesses the largest pro-
jection for the upper left corner of the curve in the three
parameters in both sexes (AUCFMI = AUCBMI, in women),Table 4 Parameters’ Odds ratio of MetS in both sexes using t
Men
Disorder wald X2 OR(95% CI) p
Age 0.142 0.920(0.595-1.422)
BMI (≥24) 3.951 4.783(1.022-22.381)
BF% (>25 or 30) 0.149 0.871(0.431-1.760)
TC (≥5.71) 0.051 1.060(0.638-1.762)
LDL (≥4.14) 3.590 0.517(0.261-1.023)
CRP (quartile) 40.434 1.844(1.527-2.227)
Exercise status 0.494 0.849(0.538-1.341)
Smoking status 0.012 0.978(0.649-1.473)which indicates its best predictive potential among the
the parameters.
Discussion
Metabolic syndrome is associated with the development
of diabetes, cardiovascular disease, which is the leading
cause of mortality worldwide [27] and epidemical in
China and other economically developing countries in
recent decades [28]. In addition, MetS was associated
with arteral stiffness, which was a cardiovascular out-
come of MetS [29]. Therefore, it is very important to de-
velop an effective screening tool of metabolic syndrome
in practice in China.
To our best knowledge, this is the first large cross-
sectional study that examined the association of fat mass
index quartiles (by BIA) and metabolic syndrome and
determine the optimal cut-off values of fat mass index in
prediction of metabolic syndrome in practice in Chinese
population.
In this study, BMI, BF% and FMI were used to screen
the presence of metabolic syndrome. One study [30]
concluded that the BMI, waist circumference and waist-
to-height ratio can predict the presence of multiple
metabolic risk factors in Chinese subjects, but parame-
ters including WC were not used in this study, sincehe lowest quartile as the reference
Women
value wald X2 OR(95% CI) p value
0.706 10.666 2.701(1.488-4.903) 0.001
0.047 9.854 4.082(1.696-9.822) 0.002
0.700 1.037 0.570(0.193-1.682) 0.308
0.822 0.039 0.917(0.388-2.165) 0.843
0.058 0.676 0.595(0.173-2.051) 0.411
0.000 25.384 2.084(1.566-2.774) 0.000
0.482 3.655 1.835(0.985-3.419) 0.056
0.914 2.345 1.819(0.846-3.914) 0.126
Table 5 Sensitivity, specificity and AUC of cutoff value of three indicators in prediction of MetS
Indicators Cutoff value Sensitivity Specificity AUC 95%CI P value
BMI(kg/m2)
Men 27.45 0.806 0.843 0.904 0.882 ~ 0.925 0.000
Women 23.85 0.927 0.729 0.898 0.869 ~ 0.928 0.000
BF(%)
Men 23.95 0.841 0.778 0.883 0.859 ~ 0.908 0.000
Women 31.35 0.771 0.814 0.855 0.818 ~ 0.892 0.000
FMI(kg/m2)
Men 7.00 0.802 0.869 0.920 0.900 ~ 0.940 0.000
Women 7.90 0.789 0.857 0.898 0.869 ~ 0.927 0.000
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BMI is an anthropometric parameter which is widely
used to the assessment of obesity, and it is easily calcu-
lated. However, it cannot reflect body fat mass and body
fat distribution due to the differences of age, sex and
ethnic groups and obese types when BMI is used alone.
Although some studies [10,31] found that high BF% was
associated with increased cardiovascular risk regardless
of BMI whose categorization resulted in an underestima-
tion of subjects with cardiovascular risk factors [32],
people with the same BMI or the same percentage may
have very different body composition, which may result
in people with the same BMI or percentage of body fat
exposing to different metabolic conditions, therefore, it
is better to measure and express body composition as
FMI and FFMI than either BMI or BF% [33]. Among the
indicators used to predict the presence of metabolic syn-
drome, FMI was the index that showed the greatest area
under the ROC curve. In addition,our study showed that
high FMI had significantly higher Odds ratio for meta-
bolic syndrome than the low FMI in both sexes, whichROC Curve












Figure 2 Receiver-operating characteristic(ROC) analysis of BMI,
BF%, and FMI as indicators to predict MetS in men.was similar to one previous study [33], in which body
composition was measured by DXA. Our study also
showed that high FMI level was strongly associated with
the presence of MetS after adjusting BMI and BF% in
both men and women, and the adjusted odds ratios of the
risk of MetS were higher than that of BMI and BF%. More-
over, when WC was also added into regression analysis the
3rd and 4th quartiles of FMI for men and the 4th quartile of
FMI for women still had significantly higher Odds ratio for
metabolic syndrome than the lowest quartile.
Therefore,our study shows that high FMI level appears
to be independently associated with MetS regardless of
BMI and BF% and can be the effective measurement
method for the assessment of metabolic syndrome in clin-
ical practice. FMI of 7.00 kg/m2 for men and 7.90 kg/m2
for women by BIA could effectively predict the presence of
MetS in our study. A recent study [34] showed that waist-
to-height ratio, which was a better screening tool than BMI
and waist circumference for adult metabolic risk factors
demonstrated in a recent systematic review [35], was the













Figure 3 Receiver-operating characteristic(ROC) analysis of BMI,
BF%, and FMI as indicators to predict MetS in women.
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grated discrimination improvement. Data analysis for the
combination of waist-to-height ratio with FMI are not
shown in this study, further investigation should be con-
ducted with the aim at determining whether the combin-
ation is appropriate for Chinese population.
In addition, our study determined that the CRP level
were significantly higher in postmenopausal women with
MetS than those without MetS and higher CRP level is
independent factor for the presence of metabolic syn-
drome, which is consistent with one recent study [36].
In addition, the mean age was significantly higher in
MetS group than in non-MetS group (52.25 ± 9.56 vs.
45.15 ± 10.63, P < 0.001) and age seemed to be one of
the risk factors of the presence of MetS in women, the
possible reason was that postmenopausal women were
occupational in the MetS group, and postmenopausal
women are likely to have the increasing prevalence of in-
sulin resistance and obesity (particularly visceral adipos-
ity), which might contribute to the risk of MetS [14].
This study has several limitations. First, due to the
cross-sectional design, it is not possible to explore the
causal relationship between body composition and meta-
bolic syndrome. Second, our population is restricted to
20-79-year-old men and women living in Beijing,and the
result from oue study might not be applicable to other
population. Third, hypertriglyceridemia, Low HDL-c, fast-
ing hyperglucemia did not be included in the regression
analysis, because they are the essential criteria in the diag-
nosis for MetS. Fourth, the prevalence of metabolic syn-
drome with age group (particularly in women since the
post-menopause status might contribute to the risk of
MetS due to the excessive fat accumulation) was not men-
tioned in this article, and further investigation should be
performed in the future studies.
Conclusion
Despite these limitations, our study suggested that FMI
seems to be a better indicator in the screening of the pres-
ence of metabolic syndrome than BMI and percentage of
body fat in men and women.
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